Hippocratic AI is building out its life sciences division to accelerate generative and agentic artificial intelligence in the biopharma and medtech sectors. The company, which developed patient-facing generative AI healthcare agents, acquired Grove AI, a startup that offers agentic AI for pharma R&D and clinical trial operations. The company’s AI solutions aim to streamline clinical trial participant engagement, notably with an AI agent named “Grace,” with the goal of speeding up recruitment and reducing operational burdens in life sciences. Grove AI, which launched in 2024, supported more than 10 million patient interactions over the past year.
Read the full article: Hippocratic AI Acquires Grove AI //
Source: https://www.fiercehealthcare.com/ai-and-machine-learning/jpm26-hippocratic-ai-acquires-grove-ai-taps-life-sciences-leaders-focus